Plasma endothelin-1 levels in obese hypertensive and normotensive men
- PMID: 7698512
- DOI: 10.2337/diab.44.4.431
Plasma endothelin-1 levels in obese hypertensive and normotensive men
Abstract
Plasma endothelin-1 (ET-1) levels were studied in 15 obese hypertensive (mean age 48.5 +/- 3.9 years) and 15 obese normotensive men (mean age 49.5 +/- 3.6 years) before and after weight loss due to an 800 kcal/day diet lasting 12 weeks. Circulating peptide concentrations were also assessed in nonobese hypertensive (n = 11) and normotensive men (n = 12). Baseline plasma ET-1 levels were similar in obese hypertensive (0.87 +/- 0.22 pg/ml) and obese normotensive men (0.91 +/- 0.30 pg/ml). In seven obese hypertensive men, caloric restriction normalized blood pressure levels (systolic: from 166.6 +/- 8.1 to 145.0 +/- 6.3 mmHg, P < 0.0001; diastolic: from 106.6 +/- 5.1 to 89.1 +/- 2.0 mmHg, P < 0.0001) and decreased body mass index (BMI) (from 33.4 +/- 1.6 to 29.6 +/- 2.1 kg/m2, P < 0.002) and plasma ET-1 levels (from 0.93 +/- 0.21 to 0.64 +/- 0.26 pg/ml, P < 0.05). In the remaining obese hypertensive men (n = 8), blood pressure levels were not normalized by caloric restriction despite a significant decrease of BMI and plasma ET-1 levels (from 0.83 +/- 0.23 to 0.60 +/- 0.16 pg/ml, P < 0.04). Weight loss also significantly decreased BMI and ET-1 (from 0.91 +/- 0.30 to 0.65 +/- 0.19 pg/ml, P < 0.01) in obese normotensive men. Baseline ET-1 and fasting insulin levels were significantly correlated in obese hypertensive (r = 0.518, P < 0.05) and obese normotensive men (r = 0.535, P < 0.04).(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Reduction in resting metabolic rate and ratio of plasma leptin to urinary nitric oxide: influence on obesity-related hypertension.Isr Med Assoc J. 2002 Jun;4(6):426-30. Isr Med Assoc J. 2002. PMID: 12073415
-
[High circulating levels of adrenomedullin and endothelin-1 in obesity associated with arterial hypertension].Ital Heart J Suppl. 2001 Sep;2(9):1011-5. Ital Heart J Suppl. 2001. PMID: 11675821 Italian.
-
Endogenous insulin modulates circulating endothelin-1 concentrations in humans.Diabetes Care. 1996 May;19(5):504-6. doi: 10.2337/diacare.19.5.504. Diabetes Care. 1996. PMID: 8732718
-
Sympathetic nerve activity and insulin in obese normotensive and hypertensive men.Hypertension. 1996 Feb;27(2):276-80. doi: 10.1161/01.hyp.27.2.276. Hypertension. 1996. PMID: 8567052
-
Relative weight and major ischaemic heart disease events in hypertensive men.Lancet. 1989 May 6;1(8645):1005-8. doi: 10.1016/s0140-6736(89)92641-x. Lancet. 1989. PMID: 2565476 Review.
Cited by
-
The association of endothelin-1 gene polymorphism and its plasma levels with hypertension and coronary atherosclerosis.Arch Med Sci. 2019 Jul 22;17(3):613-620. doi: 10.5114/aoms.2019.86770. eCollection 2021. Arch Med Sci. 2019. PMID: 34025830 Free PMC article.
-
Retinal insulin receptor signaling in hyperosmotic stress.Vitam Horm. 2009;80:583-612. doi: 10.1016/S0083-6729(08)00620-1. Vitam Horm. 2009. PMID: 19251051 Free PMC article.
-
Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.J Clin Invest. 2001 May;107(9):1193-202. doi: 10.1172/JCI11753. J Clin Invest. 2001. PMID: 11342583 Free PMC article.
-
Dual endothelin receptor antagonism increases resting energy expenditure in people with increased adiposity.Am J Physiol Endocrinol Metab. 2022 Jun 1;322(6):E508-E516. doi: 10.1152/ajpendo.00349.2021. Epub 2022 Apr 4. Am J Physiol Endocrinol Metab. 2022. PMID: 35373585 Free PMC article. Clinical Trial.
-
Pulmonary vasoreactivity in spontaneously hypertensive rats--effects of endothelin-1 and leptin.Respir Res. 2014 Feb 5;15(1):12. doi: 10.1186/1465-9921-15-12. Respir Res. 2014. PMID: 24499246 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical